• Community News
  • Medical and Scientific News
  • Features
Canadian Hemophilia Society
  • Français
chsLogo
  • Community News
  • Medical and Scientific News
  • Features
Home / Medical and Scientific News / Novel treatments in bleeding disorders: The EHC November Review

Novel treatments in bleeding disorders: The EHC November Review

David Page | 23/11/2021

CLICK HERE to access the November 2021 review of novel treatments in haemophilia and other bleeding disorders by the European Haemophilia Consortium.

  • KEYWORDS
    ADVOCACY ageing A GLOBAL PERSPECTIVE AIDS CARRIERS CHS chapters Community COMPENSATION COVID-19 EMICIZUMAB GENE THERAPY HALF-LIFE FACTOR CONCENTRATES HEMLIBRA HEMOPHILIA A AND B HEPATITIS C HIV ICHIP INHIBITORS MYCBDR NURSING PHYSIOTHERAPY Platelet function disorders PROBE PROPHYLAXIS RARE BLEEDING DISORDERS RESEARCH SOCIAL WORK Tainted blood tragedy THE BLOOD FACTOR THE FEMALE FACTOR THERAPIES THE SAGE PAGE TWINNING VON WILLEBRAND DISEASE

Copyright © 2020 - Canadian Hemophilia Society. All rights reserved.

  • ARCHIVED HEMOPHILIA TODAY
  • ABOUT US